Cyprus Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cyprus Healthcare Press.

Press releases published on October 26, 2026

30 minutes ago

MacroGenics Announces Positive Interim Phase 2 LINNET Results for Lorigerlimab in Advanced Clear Cell Gynecologic Cancer

Indeterminate GlobeNewswire

31 minutes ago

Serapha Bio Announces Positive Interim Safety and Efficacy Data from the SERP-01 Investigator-Initiated Trial Presented at the ERS Alpha-1 Antitrypsin Conference 2026

Indeterminate GlobeNewswire

31 minutes ago

Kraig Biocraft Laboratories Launches Performance Yarn Development Program and Ships Spider Silk to Yarn and Aerospace Innovator

Indeterminate GlobeNewswire

36 minutes ago

Syndax to Announce Third Quarter 2026 Financial Results and Host Conference Call and Webcast on November 2, 2026

Indeterminate GlobeNewswire

36 minutes ago

Regeneron Extends Agreement with BARDA to Provide Additional Supply of Ebola Treatment Inmazeb® for U.S. Preparedness

Indeterminate GlobeNewswire

36 minutes ago

Tonix Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 9, 2026

Indeterminate GlobeNewswire

36 minutes ago

TILT Biotherapeutics Presents Encouraging Phase 1b Results in Ovarian Cancer at ESMO 2026

Indeterminate GlobeNewswire

36 minutes ago

Iovance Announces Data Showing Durable Responses with Lifileucel TIL Cell Therapy in Advanced Soft Tissue Sarcomas at ESMO 2026

Indeterminate GlobeNewswire

36 minutes ago

VETmAb Biosciences Announces Positive Clinical Proof-of-Concept Results for Long-Acting Anti-IL-23 Antibody in Canine Chronic Inflammatory Enteropathy

Indeterminate GlobeNewswire

36 minutes ago

Acumen Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire

36 minutes ago

Harrow To Report Third Quarter 2026 Financial Results After Market Close on November 9, 2026

Indeterminate GlobeNewswire

36 minutes ago

Eledon Pharmaceuticals Presents Phase 2 BESTOW Trial Data Showing Sustained Improvements in Quality of Life and Symptom Burden with Tegoprubart Compared to Tacrolimus at American Society of Nephrology Kidney Week 2026 Annual Meeting

Indeterminate GlobeNewswire

36 minutes ago

Oruka Therapeutics Announces Positive Week 16 Results for ORKA-001 from the Ongoing EVERLAST-B Trial in Moderate-to-Severe Psoriasis

Indeterminate GlobeNewswire

36 minutes ago

BPGbio Presents Phase 2 Glioblastoma Data Update at ESMO Congress 2026, Highlighting Median Overall Survival of 19.9 Months in MGMT-Unmethylated Patients

Indeterminate GlobeNewswire

36 minutes ago

Fate Therapeutics Presents Updated Preliminary Data for FT819 in Active Lupus Nephritis at American Society of Nephrology Kidney Week 2026

Indeterminate GlobeNewswire

36 minutes ago

Pluri and ZEO ScientifiX Partner to Expand U.S. Manufacturing and Commercial Platform for Regenerative Medicine

Indeterminate GlobeNewswire

36 minutes ago

Can-Fite Presents Final Positive Data from Phase IIa Pancreatic Cancer Study of Namodenoson at ESMO 2026

Indeterminate GlobeNewswire

an hour ago

InnoCare Reports 2026 Q3 Results, Sustained Profitability and Accelerating Globalization

Indeterminate GlobeNewswire

an hour ago

Newsweek Places KFSH in Top 4% of World's Smart Hospitals for Digital Maturity and AI

Indeterminate GlobeNewswire

2 hours ago

Eikon Therapeutics Presents Updated EIK1001 Data from TeLuRide-005 at the European Society for Medical Oncology Congress

Indeterminate GlobeNewswire